Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of interleukin 2 in preparing medicine for treating rhinitis

A technology of interleukin and human interleukin, applied in the field of biomedicine, can solve the problems of heart toxicity and side effects, aggravated nasal congestion, and inability to use it for a long time, so as to achieve definite curative effect, relieve symptoms and signs, and improve the effect of pathological changes

Inactive Publication Date: 2010-07-21
BEIJING FOUR RINGS BIOPHARM +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the main drugs for treating rhinitis and their advantages and disadvantages are as follows: (1) Antihistamines, which are absorbed quickly after oral administration, can quickly improve symptoms of nasal itching, sneezing, and runny nose, but are ineffective for nasal congestion symptoms, and have side effects such as drowsiness Larger, with some antihistamines and severe cardiotoxic side effects
(2) Nasal decongestant drugs can be applied locally or systemically. Topical drugs such as ephedrine have a quick effect and can quickly relieve nasal congestion symptoms. However, such drugs cannot be used for a long time, and usually should not exceed 4 days. Because it has the side effect of vasodilation, leading to increased nasal congestion, long-term use will inevitably cause drug-induced rhinitis, increasing the complexity of rhinitis and the difficulty of treatment
So far, there is no report on the application of interleukin 2 in the treatment of rhinitis at home and abroad

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of interleukin 2 in preparing medicine for treating rhinitis
  • Application of interleukin 2 in preparing medicine for treating rhinitis
  • Application of interleukin 2 in preparing medicine for treating rhinitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0025] Embodiment. Anti-rhinitis animal test

[0026] 1. Purpose of the test

[0027] To observe the effect of recombinant human interleukin-2 nasal spray on animal models of allergic rhinitis, and to provide pharmacological experimental basis for its clinical application.

[0028] 2. Test materials

[0029] 1. Animals: 70 clean SD rats, half male and half male, provided by the General Hospital of Nanjing Military Region, weighing 220-250 grams, animal qualification certificate number: SCXK (Su 2003-0004), raised in this laboratory for 3-3 Use after 5 days.

[0030] 2. Drugs

[0031] (1) Recombinant human interleukin-2 nasal spray. Produced by Beijing Sihuan Biopharmaceutical Co., Ltd., specification: 1 million u·ml -1 , 3ml / branch. The active ingredient is interleukin 2, which is prepared by conventional auxiliary materials and conventional operations.

[0032] (2) Berkner nasal aerosol (beclomethasone dipropionate nasal aerosol). Produced by GlaxoSmithKline Pharmaceu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses an application of the interleukin-2 (IL-2) and the derivatives in the preparation of the drugs for treating rhinitis and pertains to the field of biomedicine. The present invention has the advantages that: the present invention firstly uses the recombinant human interleukin-2 in the treatment of rhinitis, the results show that the interleukin-2 can obviously alleviate the symptoms and physical signs of the rhinitis, significantly alleviate the nasal lesions and have the accurate efficacy.

Description

technical field [0001] The invention relates to the application of interleukin 2 (interleukin-2) and derivatives thereof as medicines for treating rhinitis, and belongs to the field of biomedicine. Background technique [0002] Rhinitis refers to inflammation of the nasal mucosa, manifested as congestion or edema. Patients often experience symptoms such as nasal congestion, runny nose, nasal itching, throat discomfort, and coughing. Rhinitis is divided into allergic rhinitis, chronic rhinitis, chronic sinusitis, etc. The clinical symptoms of rhinitis are different, and the harm is extremely harmful. When the physiological function of the nasal cavity is affected, breathing disorders will occur, causing blood oxygen concentration to decrease, and affecting other tissues and organs. Some symptoms such as headache, dizziness, memory loss, chest pain, chest tightness, lethargy and other symptoms appear, and even serious complications such as emphysema, cor pulmonale, and asthma ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/20A61K9/08A61K9/12A61P11/02
Inventor 汤玥程度胜朱家壁
Owner BEIJING FOUR RINGS BIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com